Augmedix
(NASDAQ) AUGX
Augmedix Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$51.58M
Net Income (TTM)
$23.85M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AUGX News
AUGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Augmedix
Industry
Health Care Technology
Sector
Health CareEmployees
1,430
CEO
Emmanuel Krakaris, MBA
Website
www.augmedix.comHeadquarters
San Francisco, CA 94104, US
AUGX Financials
Key Financial Metrics (TTM)
Gross Margin
48%
Operating Margin
-42%
Net Income Margin
-43%
Return on Equity
-2%
Return on Capital
-44%
Return on Assets
-29%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$21.53M
Operating Income
$18.78M
EBITDA
$15.68M
Operating Cash Flow
$15.44M
Capital Expenditure
$3.10M
Free Cash Flow
$18.55M
Cash & ST Invst.
$46.34M
Total Debt
$27.34M
Augmedix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.66M
+26.8%
Gross Profit
$6.46M
+27.4%
Gross Margin
47.24%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1,430
N/A
Net Income
$8.45M
-67.9%
EBITDA
$7.31M
-75.6%
Quarterly Fundamentals
Net Cash
$1.51M
-71.6%
Accounts Receivable
$9.25M
-1.9%
Inventory
$0.00
+100.0%
Long Term Debt
$18.84M
+8.5%
Short Term Debt
$7.86M
-1.0%
Return on Assets
-28.74%
N/A
Return on Invested Capital
-43.58%
N/A
Free Cash Flow
$4.25M
+41.4%
Operating Cash Flow
$3.89M
+34.7%